Since its introduction in 1983 (11), the baculovirus system has become widely used in studies on eukaryotic proteins, especially those synthesized in the rough endoplasmic reticulum. In a few cases, heterogeneity has been observed in proteins produced in Spodopteracells, pointing to limited proteolysis such as amyloid precursor protein (9) , interferon α 2 (12) and muscarinic M2 receptor (3) . In an extreme case, extensive degradation of proapolipoprotein A-1 in Sf21 cells has been described in a protein-free medium (8) . Blockage of this degradation by leupeptin and pepstatin A suggests that conventional proteinases are involved. Because of advantages of using serumfree medium for the production of recombinant proteins, we have carried out studies on the proteolytic activity contributed by Spodopteracells and the virus and on protection of a proteinasesensitive precursor protein.
Human procathepsin D cDNA (5) was cloned into the Eco RI site of the vector pVL 1393 (Invitrogen, Leek, The Netherlands), and recombinant virus was prepared with Autographa californicamononuclear polyhedrosis virus AcMNPV (10) . In infected Spodoptera frugiperda IPLB-SF-21AE (Sf21) cells, production of human cathepsin D was detected by the increase in pepstatin Asensitive hemoglobin hydrolyzing activity and in a Western blot using a monoclonal anti-cathepsin D antibody. Production reached a maximum at about six days postinfection. After metabolic labeling of infected cells with [ 35 S]methionine, immunoprecipitation, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and fluorography, most of the antigen was found in the medium following a chase of up to 16 h (data not shown). In Hink's medium (4) containing 10% (vol/vol) heat-inactivated fetal bovine serum, the maximum yield of procathepsin D was 1.5 mg/L medium. In the serum-free medium SF900II (media and supplements were from Life Technologies, Eggenstein, Germany), the yield was 2.5 mg/L. Because of the higher yield and its low protein content, the SF900II medium appeared convenient for the purification of the recombinant procathepsin D. However, the apparent size of the product was less in this medium than in Hink's medium (compare the first two lanes in Figure  1) . From the following observations, it was concluded that the decrease in the apparent size was caused by proteolysis: (i) a difference in the apparent size was observed even after deglycosylation with glycopeptidase F (not shown); (ii) the difference was abolished when the protein-free medium was supplemented with a mixture of proteinase inhibitors ( Figure 1) ; and (iii) cathepsin D produced in the absence of inhibitors in the protein-free medium, unlike that in Hink's medium, did not react with a rabbit antiserum that was raised against the N-terminal portion of procathepsin D [i.e., a peptide consisting of residues H-38-G-24 (2)].
We have observed that in the course of infection, the pH of Sf21 cell cul930BioTechniques Figure 1 . Effect of proteinase inhibitors on the apparent size of procathepsin D expressed in Sf21 cells. The cells were infected at a multiplicity of infection (MOI) of 10, and the medium was collected after 5 days. Aliquots of medium were subjected to SDS-PAGE under reducing conditons. After a semidry transfer to a polyvinylidene fluoride membrane, the antigen was detected using mouse monoclonal anti-human cathepsin D antibody 3G8 and goat anti-mouse IgG (H+L) horseradish peroxidase conjugate (Bio-Rad Laboratories, München, Germany). H: Hink's medium with 10% heat-inactivated fetal bovine serum (20 µ L); S: SF900II protein-free (10 µ L). A cocktail of inhibitors (+) was used that consisted of (final concentrations): 10 µ M pepstatin A (Sigma Chemie, Deisenhofen, Germany), 2 µ M leupeptin, 10 µ M E-64, 10 µ g/mL bovine α 2 -macroglobulin, 1 mM Pefabloc SC and 10 µ M Z-Phe-Phe-diazomethylketone.
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The medium was sampled 5 days after infection with the virus encoding procathepsin D. The assay with [ 14 C]carbamoyl hemoglobin was performed for 1 h at 37°C, pH 5.2 in the presence of 10 µ M pepstatin A with or without additional inhibitors. The reaction was stopped by adding trichloroacetic acid to a final concentration of 10% (wt/vol). The radioactivity associated with fragments soluble in the acid was determined by liquid scintillation counting (5) . Activity in the absence and the presence of pepstatin A was 75 ±5 and 42 ±4 (100%) µ g hemoglobin/mL/h, respectively. The determinations were performed in triplicate.
Table 1. Inhibition of Pepstatin-Resistant Proteolytic Activity in the Medium of Infected Sf21 Cells
Benchmark s tures drops to 5.5, and neutral and acidic proteinases are likely to endanger the secreted proteins. Therefore, we examined proteolytic activity in the medium at a weakly acidic condition with hemoglobin as substrate. In the medium from cells that had been infected with baculovirus encoding procathepsin D, a little less than half of the measured proteolytic activity was sensitive to pepstatin A. As shown in Table  1 , the residual activity was sensitive to several inhibitors including α 2 -macroglobulin and inhibitors of serine and cysteine proteinases. A mixture consisting of leupeptin, Pefabloc ® SC (Boehringer Mannheim GmbH, Mannheim, Germany), α 2 -macroglobulin, E-64 and Z-Phe-Phe-diazomethylketone (Bachem AG, Heidelberg, Germany) inhibited the pepstatin A-resistant activity by approximately 80%. Together with pepstatin A, this mixture was not toxic to Sf21 cells under our culture conditions. This mixture prevented the proteolysis of procathepsin D in SF900II medium ( Figure 1 ) and can be recommended as a supplement to serum-free media in the production of recombinant proteins. Because α 2 -macroglobulin is a protein, it may interfere with purification of recombinant proteins, although its M r of approximately 8 ×10 5 should allow a convenient separation in most cases. We examined protection of the protein by Western blot analysis. With the polyclonal antibody raised against residues H-38-G-24 of procathepsin D mentioned above, the precursor was clearly observed in the presence of the inhibitor mixture (data not shown). In the absence of the inhibitors, SF900II medium conditioned with Sf21 cells contained a considerable acid proteinase activity. This was established with our standard assay of cathepsin D using hemoglobin as a substrate at pH 3.65 to characterize the expression of cathepsin D and the activity of the endogenous proteinases in the system. As shown in Figure 2 , the activity increased approximately twofold when the cells were infected, and this did not seem to depend on the expression of cathepsin D. However, the expression of the recombinant protein strongly increased the pepstatin-sensitive proteolytic activity. It is likely that the replacement of the polyhedrin gene results in a decrease of expression of certain host proteinases. The secreted activity was strongly though not completely inhibited in the presence of a cocktail of inhibitors directed against cysteine, serine and aspartic proteinases. A stronger inhibition was observed when iodoacetamide was included. However, this inhibitor is toxic and cannot be used during cell culture.
The widely used baculovirus encodes a leupeptin-sensitive cysteine proteinase activity (1, 6) that is released into the medium of infected cells. A mutant has been described with the proteinase gene deleted (7) that may limit the problem of proteolysis to the action of cell-derived proteinases. However, with homoglobin as substrate, it is observed that both noninfected and infected Sf21 cells release proteinases. Different amounts of various proteinases were released depending on the presence of a virus. This report extends the findings of Pyle et al. (8) and characterizes the complexity of the proteinase activity in baculovirusinfected cells. It adds serine proteinases to the list of the proteolytic enzymes that are released from baculovirus-infected cells and may endanger the proteins synthesized in the system. In combination with a serum-free medium, the proposed mixture of six cell-compatible, commercially available inhibitors directed to several classes of proteinases can facilitate production and isolation of intact recombinant proteins. Figure 2 . Inhibition of acid proteinase activity with a mixture of proteinase inhibitors and pepstatin A. The inhibitor cocktail (C) was the same as described in the legend of Figure 1 . Where indicated, pepstatin A was omitted (C-P) or present alone (P). The media were collected after 5 days culturing of noninfected and infected Sf21 cells as defined in the figure. The assay was performed for 1 h at pH 3.65 and 37°C.
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